We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Global Refurbished Medical Devices Market to Increase by 10% by 2023

By HospiMedica International staff writers
Posted on 20 Nov 2018
The global refurbished medical devices market is expected to grow at a CAGR of over 10% during the forecast period 2019-2023, driven by the organized healthcare ecosystem in the developed economies. More...
Moreover, privatization in the healthcare sector is increasing rapidly due to the inability of governments to invest efficiently in the sector, coupled with high demand for innovation and technology for superior healthcare services.

These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

Based on product, the diagnostic imaging equipment segment held the largest share of close to 76% in the refurbished medical devices market in 2018 and is expected to maintain its dominance during the forecast period. Geographically, the Americas held the largest share of close to 44% in the global refurbished medical devices market in 2018, followed by the EMEA and APAC regions, respectively. The North American refurbished medical devices market is being driven by high investments in healthcare in countries such as the US and Canada.

Medical equipment and devices involve huge costs, which can be attributed to high R&D and technology costs associated with designing new medical devices. Additionally, medical devices generally contain various redundant and high-end components to reduce the probability of device failure, which further increases their manufacturing cost. This high cost of new medical devices makes it lucrative for healthcare service providers to use refurbished medical devices.

“Due to the high cost of new medical devices, refurbished medical devices serve as cost-effective alternatives,” said a senior analyst at Technavio. “They are certified, updated with new technologies, and have valid warranties. Refurbished medical devices enable healthcare service providers to stay updated with the latest consumer demand, at affordable prices.”

Related Links:
Technavio Research


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
OR Table Accessory
Angular Accessory Rail
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.